Send to

Choose Destination
See comment in PubMed Commons below
Presse Med. 2009 Feb;38(2):243-50. doi: 10.1016/j.lpm.2008.10.010. Epub 2008 Nov 28.

[Pneumococcal infections and vaccination in patients with systemic autoimmune and/or inflammatory diseases].

[Article in French]

Author information

  • 1Centre d'Investigation Clinique de Vaccinologie Cochin Pasteur, Pôle de Médecine, Groupe Hospitalier Cochin Saint-Vincent-de-Paul, Assistance Publique-Hôpitaux de Paris, Paris Cedex 14, France.


Patients with systemic autoimmune and/or inflammatory diseases have an increased risk of infections, particularly pneumoccocal invasive infections. Vaccination can prevent these infections. Available data about immunogenicity and safety of pneumococcal polysaccharide vaccine in these patients indicate that, it remains well tolerated and most of the time immunogenic, even if the antibody response is lower compared to healthy controls. These data encourage to vaccinate these patients with pneumococcal vaccine. However, the lack of data confirming the clinical efficacy of this vaccination, the theoretical risk of disease relapse following vaccine administration and the lack of specific recommendations guiding the decision to vaccinate these patients contribute to the low vaccine coverage. More immunogenic vaccine strategy should be evaluated in patients with systemic autoimmune and/or inflammatory diseases to provide better vaccine coverage.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk